Difference between revisions of "CNS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Editor updated for a page on volunteer assignments)
 
(7 intermediate revisions by one other user not shown)
Line 5: Line 5:
 
If empty (no name is present), please volunteer to create content for that disease!
 
If empty (no name is present), please volunteer to create content for that disease!
  
−
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
+
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
−
 
 
−
<br />
 
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 19: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|Astrocystoma, IDH-Mutant
+
|CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|Meenakshi Mehrotra
 
|Meenakshi Mehrotra
Line 30: Line 48:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
+
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 +
|Disease
 +
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
|6/7/2022
 
|6/7/2022
 
|
 
|
Line 39: Line 59:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
+
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 +
|Disease
 +
|Meenakshi Mehrotra
 
|
 
|
 
|
 
|
Line 46: Line 68:
 
|LS
 
|LS
 
|
 
|
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
+
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
 
|-
 
|-
−
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
+
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|Scott Smith
 
|6/27/2023
 
|6/27/2023
 
|
 
|
Line 57: Line 81:
 
|2021 template added (page created 6/27/23)
 
|2021 template added (page created 6/27/23)
 
|-
 
|-
−
|Angiocentric Glioma||Disease||
+
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 66: Line 92:
 
|
 
|
 
|-
 
|-
−
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
+
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 75: Line 103:
 
|
 
|
 
|-
 
|-
−
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
+
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
−
|
+
|Disease
−
|
+
|Scott Smith
−
|
+
|5/3/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
+
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 
|
 
|
 
|
 
|
Line 93: Line 125:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
+
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|Xiaolin (Lynn) Hu
 
|2/21/2022
 
|2/21/2022
 
|
 
|
Line 102: Line 136:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
+
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|Madina Sukhanova
 
|10/28/2022
 
|10/28/2022
 
|
 
|
Line 111: Line 147:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Infant-Type Hemispheric Glioma||Disease||
+
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 118: Line 157:
 
|
 
|
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
+
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 +
|Disease
 +
|Jeremy Pulvers
 
|9/13/2022<br />
 
|9/13/2022<br />
 
|
 
|
Line 129: Line 169:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|High-Grade Astrocytoma with Piloid Features||Disease||
+
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 138: Line 180:
 
|
 
|
 
|-
 
|-
−
|Pleomorphic Xanthoastrocytoma||Disease||
+
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 147: Line 191:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Subependymal Giant Cell Astrocytoma||Disease||
+
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 156: Line 202:
 
|
 
|
 
|-
 
|-
−
|Chordoid Glioma||Disease||
+
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 165: Line 213:
 
|
 
|
 
|-
 
|-
−
|Astroblastoma, MN1-Altered||Disease||
+
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 174: Line 224:
 
|
 
|
 
|-
 
|-
−
|Ganglioglioma||Disease||Leila Moayed-Aloei
+
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|Leila Moayed-Aloei
 
|6/30/2022
 
|6/30/2022
 
|
 
|
Line 183: Line 235:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Gangliocytoma||Disease||
+
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 192: Line 246:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
+
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 201: Line 257:
 
|
 
|
 
|-
 
|-
−
|Dysembryoplastic Neuroepithelial Tumour||Disease||
+
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 210: Line 268:
 
|
 
|
 
|-
 
|-
−
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
+
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 219: Line 279:
 
|
 
|
 
|-
 
|-
−
|Papillary Glioneuronal Tumour||Disease||
+
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 228: Line 290:
 
|
 
|
 
|-
 
|-
−
|Rosette-Forming Glioneuronal Tumour||Disease||
+
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 237: Line 301:
 
|
 
|
 
|-
 
|-
−
|Myxoid Glioneuronal Tumour||Disease||
+
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 246: Line 312:
 
|
 
|
 
|-
 
|-
−
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
+
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 255: Line 323:
 
|
 
|
 
|-
 
|-
−
|Multinodular and Vacuolating Neuronal Tumour||Disease||
+
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 264: Line 334:
 
|
 
|
 
|-
 
|-
−
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
+
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 273: Line 345:
 
|
 
|
 
|-
 
|-
−
|Central Neurocytoma||Disease||
+
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 282: Line 356:
 
|
 
|
 
|-
 
|-
−
|Extraventricular Neurocytoma||Disease||
+
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 291: Line 367:
 
|
 
|
 
|-
 
|-
−
|Cerebellar Liponeurocytoma||Disease||
+
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 300: Line 378:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 309: Line 389:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
−
|
+
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 318: Line 400:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 327: Line 411:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 336: Line 422:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 345: Line 433:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 354: Line 444:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma||Disease||
+
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 363: Line 455:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma, MYCN-Amplified||Disease||
+
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 372: Line 466:
 
|
 
|
 
|-
 
|-
−
|Myxopapillary Ependymoma||Disease||
+
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 381: Line 477:
 
|
 
|
 
|-
 
|-
−
|Subependymoma||Disease||
+
|[[CNS5:Subependymoma|Subependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 390: Line 488:
 
|
 
|
 
|-
 
|-
−
|Choroid Plexus Papilloma||Disease||
+
|CHAPTER 3 (CHOROID PLEXUS TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Atypical Choroid Plexus Papilloma||Disease||
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Choroid Plexus Carcinoma||Disease||
 
 
|
 
|
 
|
 
|
Line 417: Line 519:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
−
|9/20/21
+
|Disease
−
|
 
−
|COMPLETE
 
 
|
 
|
−
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 
−
|9/22/2022
 
−
|2021 template added
 
−
|-
 
−
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
 
 
|
 
|
 
|
 
|
Line 435: Line 530:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
+
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 444: Line 541:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
+
|CHAPTER 4 (EMBRYONAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Medulloblastoma, Histologically Defined||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 +
|Disease
 +
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 +
|9/20/21
 
|
 
|
 +
|COMPLETE
 
|
 
|
 +
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 +
|9/22/2022
 +
|2021 template added
 +
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Atypical Teratoid/Rhabdoid Tumour||Disease||
 
 
|
 
|
 
|
 
|
Line 468: Line 582:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Cribriform Neuroepithelial Tumour||Disease||
 
 
|
 
|
 
|
 
|
Line 478: Line 593:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Embryonal Tumour with Multilayered Rosettes||Disease||
 
 
|
 
|
 
|
 
|
Line 489: Line 605:
 
|
 
|
 
|-
 
|-
−
|CNS Neuroblastoma, FOXR2-Activated||Disease||
+
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 498: Line 616:
 
|
 
|
 
|-
 
|-
−
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
+
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 507: Line 627:
 
|
 
|
 
|-
 
|-
−
|CNS Embryonal Tumour NEC/NOS||Disease||
+
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 516: Line 638:
 
|
 
|
 
|-
 
|-
−
|Pineocytoma||Disease||
+
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 525: Line 649:
 
|
 
|
 
|-
 
|-
−
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
+
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
−
|
+
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 534: Line 660:
 
|
 
|
 
|-
 
|-
−
|Pineoblastoma||Disease||
+
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 543: Line 671:
 
|
 
|
 
|-
 
|-
−
|Papillary Tumour of the Pineal Region||Disease||
+
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 552: Line 682:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
+
|CHAPTER 5 (PINEAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Schwannoma||Disease||
+
|[[CNS5:Pineocytoma|Pineocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 570: Line 713:
 
|
 
|
 
|-
 
|-
−
|Neurofibroma||Disease||
+
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 579: Line 724:
 
|
 
|
 
|-
 
|-
−
|Perineurioma||Disease||
+
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 588: Line 735:
 
|
 
|
 
|-
 
|-
−
|Hybrid Nerve Sheath Tumours||Disease||
+
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 597: Line 746:
 
|
 
|
 
|-
 
|-
−
|Malignant Melanotic Nerve Sheath Tumour||Disease||
+
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 606: Line 757:
 
|
 
|
 
|-
 
|-
−
|Malignant Peripheral Nerve Sheath Tumour||Disease||
+
|CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[CNS5:Schwannoma|Schwannoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
 
 
|
 
|
 
|
 
|
Line 624: Line 788:
 
|
 
|
 
|-
 
|-
−
|Meningioma||Disease||
+
|[[CNS5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 633: Line 799:
 
|
 
|
 
|-
 
|-
−
|Solitary Fibrous Tumour||Disease||
+
|[[CNS5:Perineurioma|Perineurioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 642: Line 810:
 
|
 
|
 
|-
 
|-
−
|Haemangiomas and Vascular Malformations||Disease||
+
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 651: Line 821:
 
|
 
|
 
|-
 
|-
−
|Haemangioblastoma||Disease||
+
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 660: Line 832:
 
|
 
|
 
|-
 
|-
−
|Rhabdomyosarcoma||Disease||
+
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 669: Line 843:
 
|
 
|
 
|-
 
|-
−
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
+
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 678: Line 854:
 
|
 
|
 
|-
 
|-
−
|CIC-Rearranged Sarcoma||Disease||
+
|CHAPTER 7 (MENINGIOMA)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
+
|[[CNS5:Meningioma|Meningioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 696: Line 885:
 
|
 
|
 
|-
 
|-
−
|Ewing Sarcoma||Disease||
+
|CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Mesenchymal Chondrosarcoma||Disease||
+
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 714: Line 916:
 
|
 
|
 
|-
 
|-
−
|Chondrosarcoma||Disease||
+
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 723: Line 927:
 
|
 
|
 
|-
 
|-
−
|Chordoma||Disease||
+
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 732: Line 938:
 
|
 
|
 
|-
 
|-
−
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
+
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 741: Line 949:
 
|
 
|
 
|-
 
|-
−
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
+
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 750: Line 960:
 
|
 
|
 
|-
 
|-
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
+
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 759: Line 971:
 
|
 
|
 
|-
 
|-
−
|Immunodeficiency-Associated CNS Lymphomas||Disease||
+
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 768: Line 982:
 
|
 
|
 
|-
 
|-
−
|Lymphomatoid Granulomatosis||Disease||
+
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 777: Line 993:
 
|
 
|
 
|-
 
|-
−
|Intravascular Large B-cell Lymphoma||Disease||
+
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
−
|
+
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 786: Line 1,004:
 
|
 
|
 
|-
 
|-
−
|MALT Lymphoma of the Dura||Disease||
+
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 795: Line 1,015:
 
|
 
|
 
|-
 
|-
−
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
+
|[[CNS5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 804: Line 1,026:
 
|
 
|
 
|-
 
|-
−
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
+
|CHAPTER 9 (MELANOCYTIC TUMOURS)
−
|7/2/2023
 
 
|
 
|
−
|PENDING
+
----
−
|
 
−
|MS
 
 
|
 
|
−
|2021 template added
+
----
−
|-
 
−
|T-cell and NK/T-cell Lymphomas||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Erdheim-Chester Disease||Disease||
+
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 831: Line 1,057:
 
|
 
|
 
|-
 
|-
−
|Rosai-Dorfman Disease||Disease||
+
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 840: Line 1,068:
 
|
 
|
 
|-
 
|-
−
|Juvenile Xanthogranuloma||Disease||
+
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Langerhans Cell Histiocytosis||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 857: Line 1,095:
 
|
 
|
 
|
 
|
−
|-
 
−
|Histiocytic Sarcoma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Germ Cell Tumours of the CNS||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Adamantinomatous Craniopharyngioma||Disease||
 
 
|
 
|
 
|
 
|
Line 882: Line 1,120:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Papillary Craniopharyngioma||Disease||
 
 
|
 
|
 
|
 
|
Line 892: Line 1,131:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
 
 
|
 
|
 
|
 
|
Line 903: Line 1,143:
 
|
 
|
 
|-
 
|-
−
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
+
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 912: Line 1,154:
 
|
 
|
 
|-
 
|-
−
|Pituitary Blastoma||Disease||
+
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|MS
 
|
 
|
 +
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
 +
|-
 +
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Metastases to the Meninges||Disease||
 
 
|
 
|
 
|
 
|
Line 936: Line 1,186:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
 
 
|
 
|
 
|
 
|
Line 946: Line 1,197:
 
|
 
|
 
|
 
|
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Neurofibromatosis Type 2||Disease||
+
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 957: Line 1,209:
 
|
 
|
 
|-
 
|-
−
|Schwannomatosis||Disease||
+
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 966: Line 1,220:
 
|
 
|
 
|-
 
|-
−
|Von Hippel-Lindau Syndrome||Disease||
+
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 975: Line 1,231:
 
|
 
|
 
|-
 
|-
−
|Tuberous Sclerosis||Disease||
+
|CHAPTER 11 (GERM CELL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Li-Fraumeni Syndrome||Disease||
+
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 993: Line 1,262:
 
|
 
|
 
|-
 
|-
−
|Cowden Syndrome||Disease||
+
|CHAPTER 12 (TUMOURS OF THE SELLAR REGION
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
 
−
|7/2/2023
 
 
|
 
|
−
|PENDING
+
----
 
|
 
|
−
|LS
+
----
−
|
 
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
+
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
−
|8/22/2023
+
|Disease
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS/MS
 
−
|
 
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
 
 
|
 
|
 
|
 
|
Line 1,027: Line 1,292:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Rhabdoid Tumour Predisposition Syndrome||Disease||
 
 
|
 
|
 
|
 
|
Line 1,038: Line 1,304:
 
|
 
|
 
|-
 
|-
−
|Carney Complex||Disease||
+
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,047: Line 1,315:
 
|
 
|
 
|-
 
|-
−
|DICER1 Syndrome||Disease||Jennie Thurston
+
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
−
|7/2/2023
+
|Disease
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS
 
−
|
 
−
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|Familial Paraganglioma Syndromes||Disease||
 
 
|
 
|
 
|
 
|
Line 1,063: Line 1,325:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Melanoma-Astrocytoma Syndrome||Disease||
 
 
|
 
|
 
|
 
|
Line 1,074: Line 1,337:
 
|
 
|
 
|-
 
|-
−
|Familial Retinoblastoma||Disease||
+
|CHAPTER 13 (METASTASES TO THE CNS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|BAP1 Tumour Predisposition Syndrome||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,091: Line 1,364:
 
|
 
|
 
|
 
|
−
|-
 
−
|Fanconi Anaemia||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
−
|
+
|-
−
|
+
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
−
|
 
−
|
 
−
|-
 
−
|ELP1-Medulloblastoma Syndrome||Disease||
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|}<br />
 
−
{| class="wikitable" style="margin:auto"
 
−
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
 
−
|-
 
−
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
 
−
!'''Date Assigned to Author'''
 
−
!'''Target Completion Date'''
 
−
!'''Author Content (Pending or Complete)'''
 
−
!'''Date Completed by Author'''!!'''Associate Editor'''
 
−
!'''Date of Last Editor Review'''
 
−
!'''Notes'''
 
−
|-
 
−
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
−
|Disease
 
−
|Meenakshi Mehrotra
 
−
|6/25/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|Laveniya Satgunaseelan (LS)
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 
−
|Disease
 
−
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
−
|6/7/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 
−
|Disease
 
−
|Meenakshi Mehrotra
 
−
|
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
 
−
|-
 
−
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 
−
|Disease
 
−
|Scott Smith
 
−
|6/27/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added (page created 6/27/23)
 
−
|-
 
−
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 
−
|Disease
 
−
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 
−
|
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 
−
|Disease
 
−
|Xiaolin (Lynn) Hu
 
−
|2/21/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 
−
|Disease
 
−
|Madina Sukhanova
 
−
|10/28/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 
−
|Disease
 
−
|Jeremy Pulvers
 
−
|9/13/2022<br />
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 
−
|Disease
 
−
|Leila Moayed-Aloei
 
−
|6/30/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Subependymoma|Subependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 
−
|Disease
 
−
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 
−
|9/20/21
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 
−
|9/22/2022
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineocytoma|Pineocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Schwannoma|Schwannoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Neurofibroma|Neurofibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Perineurioma|Perineurioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Meningioma|Meningioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chordoma|Chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 
−
|Disease
 
−
|Jennie Thurston
 
−
|7/2/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|MS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 
 
|Disease
 
|Disease
 
|
 
|
Line 2,222: Line 1,379:
 
|
 
|
 
|-
 
|-
−
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
+
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 
−
|Disease
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
 
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]

Latest revision as of 18:45, 2 May 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 PENDING Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Meenakshi Mehrotra PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 PENDING LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan (Linda Cooley - previous version) PENDING LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Jeremy Pulvers 9/13/2022
 PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
CHAPTER 7 (MENINGIOMA)
Meningioma Disease
CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease
CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease Ngoni Faya (trainee) + Madina Sukhanova NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Neurofibromatosis type 2 Disease
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease
Cowden syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease Jennie Thurston 7/2/2023 PENDING LS NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Familial adenomatous polyposis 1 Disease Jennifer Laffin 8/22/2023 PENDING LS/MS NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease Jennie Thurston 7/2/2023 PENDING LS NOT YET CREATED - See page "DICER1-Related Tumour Predisposition Syndrome (DICER1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=14415"